Shaolei Lu
- Cancer Research top 10%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Cancer Cells and Metastasis 6
- Cancer Diagnosis and Treatment 5
- Immunology and Allergy top 5%
- Health Informatics top 10%
-
- Epigenetics and DNA Methylation 8
-
- Neuroendocrine Tumor Research Advances 6
-
- SARS-CoV-2 and COVID-19 Research 6
-
- Metastasis and carcinoma case studies 5
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Murray B. ResnickArthur M. MercurioAshraf KhanEvgeny YakirevichShamlal MangrayKarl SiminKara A. LombardoLelia Noble
- Journals
- Human Pathology (10 papers)Modern Pathology (4 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (4 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Shaolei Lu
72 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 274
- Oncology 474
- Immunology and Allergy 104
- Health Informatics 21
- Molecular Biology 582
Countries citing papers authored by Shaolei Lu
This map shows the geographic impact of Shaolei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaolei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaolei Lu more than expected).
Fields of papers citing papers by Shaolei Lu
This network shows the impact of papers produced by Shaolei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaolei Lu. The network helps show where Shaolei Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shaolei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2020 | 35 | |
| 14 | 2019 | 4 | |
| 15 | 2016 | 10 | |
| 16 | 2016 | 17 | |
| 17 | 2015 | 10 | |
| 18 | 2013 | 13 | |
| 19 | 2011 | 79 | |
| 20 | 2005 | 33 |
About Shaolei Lu
Shaolei Lu is a scholar working on Oncology, Immunology and Allergy, Pathology and Forensic Medicine, Cancer Research and Rheumatology, having authored 81 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Neuroendocrine Tumor Research Advances (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Cancer Cells and Metastasis (6 papers), Metastasis and carcinoma case studies (5 papers), Genetic factors in colorectal cancer (5 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (274 citations), Oncology (474 citations), Immunology and Allergy (104 citations), Health Informatics (21 citations) and Molecular Biology (582 citations). Shaolei Lu has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Murray B. Resnick, Arthur M. Mercurio, Ashraf Khan, Evgeny Yakirevich, Shamlal Mangray, Karl Simin, Kara A. Lombardo, Lelia Noble, Alexander S. Brodsky and Dongfang Yang. Their work appears in journals such as Human Pathology, Modern Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Cancer Research and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.